483 Sciegen Pharmaceuticals Sep 2011

483 Sciegen Pharmaceuticals Sep 2011

Neil Bonzagni FDA, Robert Horan FDA$119.00 - Available Now

FDA investigators audited the Sciegen Pharmaceuticals - Hauppauge, NY, United States facility and issued inspectional observations (via FDA 483) on 16 Sep 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Sep 2011
  • Location: Hauppauge, United States
  • FEI: 3008298016
Add To Cart